Anzu Agentic AI Clinical Platform

AIGP Health Pte. Ltd. is a Singapore company founded by a clinician and a patient advocate, led by co-founder and CEO Dr Anindita Santosa and co-founder Sheetal Nanwani Doshi. It builds clinical AI for Southeast Asia to reduce documentation load and clinical risk in clinics and hospitals.

Anzu covers the whole consult. Before the visit, patients check in via a secure link so history, red flags and triage are ready. During the visit, a six-agent scribe documents history, examination, diagnosis and medications in real time. Afterwards it drafts summaries, referrals and letters, orders labs and schedules follow-up, including via WhatsApp. Modules include medication reconciliation, chat with the EHR and a rheumatology variant with DAS28/CRP tracking.

• Pre-consult intake: secure magic-link check-in collects history, red flags and triage before the visit.
• Six-agent scribe: documents history, examination, diagnosis, medications and protocols in real time.
• Post-consult automation: drafts summaries, referrals and letters, orders labs and schedules follow-up.
• Clinical risk support: medication reconciliation, drug interaction checks and differential diagnosis support.
• Chat with EHR: answers questions on the patient record with guideline retrieval.
• Multilingual engagement: interface languages include English, Malay, Chinese, Tamil and Bahasa Indonesia.

Private clinics in Vietnam could use digital pre-consult intake to shorten queues and prepare doctors before each visit. Chronic disease and rheumatology clinics could track disease scores and automate follow-up messages. Hospital groups could pilot agentic documentation in outpatient departments alongside their existing HIS.

Patients arrive with history and triage already captured, shortening the consultation. Documentation, referrals and follow-up are drafted by the end of the visit while the clinician keeps final control. Registered with Singapore HSA as a Class A medical device and backed by SOC 2 Type II security. Supports more than 3,000 live patients across Singapore and Australia, per the company.

AI scribes are evolving into agentic tools that handle intake, triage and follow-up as well as notes, and regulators such as Singapore's HSA are starting to register them as medical devices. Southeast Asian clinics, including in Vietnam, face multilingual patient populations and staff shortages, which favours tools built for the region.

AIGP Health Pte. Ltd. (UEN 202417899E), Singapore. Anzu is registered with Singapore HSA as a Class A medical device; SOC 2 Type II certified; complies with the PDPA. Operates in Singapore, Australia and Thailand; partner Borderless Healthcare Group.